Wolverine Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,300
Closed -$314K 1714
2024
Q3
$314K Hold
4,300
﹤0.01% 956
2024
Q2
$288K Hold
4,300
﹤0.01% 943
2024
Q1
$117K Sell
4,300
-2,500
-37% -$70K ﹤0.01% 1029
2023
Q4
$211K Sell
6,800
-148,200
-96% -$3.84M ﹤0.01% 1043
2023
Q3
$3.91M Buy
155,000
+100,300
+183% +$2.29M 0.04% 377
2023
Q2
$1.15M Buy
54,700
+42,600
+352% +$808K 0.01% 646
2023
Q1
$206K Sell
12,100
-56,800
-82% -$1.1M ﹤0.01% 1031
2022
Q4
$1.38M Buy
68,900
+10,400
+18% +$201K 0.01% 665
2022
Q3
$1.26M Buy
58,500
+53,000
+964% +$1.27M 0.01% 711
2022
Q2
$108K Buy
5,500
+3,900
+244% +$81.7K ﹤0.01% 1370
2022
Q1
$37K Hold
1,600
﹤0.01% 1608
2021
Q4
$43K Buy
+1,600
New +$45.7K ﹤0.01% 1548
2021
Q2
Sell
-2,500
Closed -$85K 2278
2021
Q1
$85K Sell
2,500
-19,100
-88% -$730K ﹤0.01% 1495
2020
Q4
$719K Buy
+21,600
New +$789K 0.01% 740
2020
Q1
Sell
-49,900
Closed -$1.19M 1554
2019
Q4
$1.19M Hold
49,900
0.01% 576
2019
Q3
$880K Buy
49,900
+40,400
+425% +$780K 0.01% 641
2019
Q2
$243K Buy
+9,500
New +$265K ﹤0.01% 1004

Other funds holding INSM

Wolverine Asset Management's INSM Position: Q4 2024 in Review

Wolverine Asset Management sold out of Insmed (INSM) in Q4 2024, closing a stake of 597 shares — an estimated $43.6K sold.

Wolverine Asset Management first reported a position in INSM in Q2 2019 and held it in 4 quarters. The position peaked at $1.09M in Q4 2019. 438 funds tracked by Wall St. Rank hold INSM as of Q4 2024.

  • Wolverine Asset Management reported no remaining Insmed position as of Q4 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 597 Insmed shares in Q4 2024, an estimated $43.6K.
  • Wolverine Asset Management first reported a position in Insmed in Q2 2019 and held it in 4 quarters.
  • Wolverine Asset Management's Insmed position peaked at $1.09M in Q4 2019.
  • 438 funds tracked by Wall St. Rank held Insmed as of Q4 2024.

Based on Wolverine Asset Management's 13F filing for Q4 2024, filed 3 Feb 2025.